4,806 reports of this reaction
2.7% of all DIAZEPAM ORAL SOLUTION (CONCENTRATE) reports
#3 most reported adverse reaction
DRUG INEFFECTIVE is the #3 most commonly reported adverse reaction for DIAZEPAM ORAL SOLUTION (CONCENTRATE), manufactured by Alembic Pharmaceuticals Inc.. There are 4,806 FDA adverse event reports linking DIAZEPAM ORAL SOLUTION (CONCENTRATE) to DRUG INEFFECTIVE. This represents approximately 2.7% of all 177,526 adverse event reports for this drug.
Patients taking DIAZEPAM ORAL SOLUTION (CONCENTRATE) who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is a less commonly reported adverse event for DIAZEPAM ORAL SOLUTION (CONCENTRATE), but still significant enough to appear in the safety profile.
In addition to drug ineffective, the following adverse reactions have been reported for DIAZEPAM ORAL SOLUTION (CONCENTRATE):
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 4,806 FDA reports for DIAZEPAM ORAL SOLUTION (CONCENTRATE). This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 2.7% of all adverse event reports for DIAZEPAM ORAL SOLUTION (CONCENTRATE), making it one of the most commonly reported side effect.
If you experience drug ineffective while taking DIAZEPAM ORAL SOLUTION (CONCENTRATE), contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.